Aspirin in the treatment of acute migraine attacks (Q28196673)

0 references

author name string

Christian Lampl

0 references

Peter Reimnitz

0 references

Michael Voelker

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

0 references

language of work or name

English

0 references

publication date

April 2006

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

563-73

0 references

cites work

Burden of migraine in the United States: disability and economic costs

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Prostaglandin and thromboxane biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Aspirin — now we can see it

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Selective COX-2 inhibitors: is the water becoming muddy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Coxibs and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Paracetamol (acetaminophen) versus acetylsalicylic acid in migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Aspirin is efficacious for the treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Mouth-dispersible aspirin in the treatment of migraine: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Double blind study of intravenous aspirin vs placebo in the treatment of acute migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Lysine-acetylsalicylic acid in acute migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Effervescent Metoclopramide and Aspirin (Migravess) Versus Effervescent Aspirin or Placebo for Migraine Attacks: A Double-Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

21 January 2018

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Absorption kinetics of aspirin in man following oral administration of an aqueous solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563

Guidelines for controlled trials of drugs in migraine: second edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.4.563